Among 2023 IPOs, one of the top performers was RayzeBio Inc. NASDAQ: RYZB, a biotech that’s out of play now because it’s being acquired by Bristol Myers…
Apogee Therapeutics (NASDAQ:APGE – Free Report) had its target price boosted by Guggenheim from $29.00 to $44.00 in a report released on Wednesday morning, Benzinga reports. Guggenheim currently has a buy rating on the stock. A number of other analysts have also commented on APGE. Wedbush reissued an outperform rating and set a $40.00 price […]
Wall Street Breakfast: The Week Ahead seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
As more than 8,000 biotech executives, investors and analysts converge this week for the 42nd Annual J.P. Morgan Healthcare Conference the largest biotech business meeting of the year industry leaders see reasons to be optimistic.
Stocks To Watch: Inflation Data + Big Conferences in Tech, Retail And Healthcare seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.